Philip Morris International (PM) is back in focus after the U.S. Food and Drug Administration granted Modified Risk Tobacco Product orders for 20 ZYN nicotine pouch variants, a regulatory step tied directly to the company’s smoke free strategy.

For context, Philip Morris International’s share price is at US$181.17 after a 1-day share price return that declined 3.15%, while its 90-day share price return of 12.91% sits alongside a 5-year total shareholder return of 130.45%. This suggests recent momentum has built on already strong long term compounding as investors weigh the ZYN decision and earlier debt prepayment.

If the shift toward smoke free products interests you, it can be useful to see what else is changing the sector. Take a look at 18 top founder-led companies

So is Philip Morris International’s recent pullback after the ZYN news a sign that expectations ran ahead of reality, or does it open a gap between the share price and what the current business mix might justify on valuation?

Most Popular Narrative: 6.2% Undervalued

With Philip Morris International closing at $181.17 against a narrative fair value of $193.14, the current pullback sits slightly below that central estimate, putting more attention on what is driving that figure.

The accelerating global adoption of smoke-free alternatives, driven by increasing health awareness and regulatory moves away from combustibles, is associated with strong double-digit volume and margin growth in PMI's IQOS, ZYN, and VEEV platforms. This secular shift enables the company to capture new consumer segments, expand its addressable market, and structurally boost net revenues and operating margins over time.

Want to see what sits behind that smoke free tilt, earnings mix assumptions and the premium profit multiple baked into this fair value view? The full narrative lays out the growth, margin and valuation blueprint in detail.

Result: Fair Value of $193.14 (UNDERVALUED)

However, the Philip Morris International story could look different if smoke free earnings fall below current analyst expectations or if new regulations compress margins more than currently modeled.

Another View: Philip Morris International Through the Earnings Multiple Lens

The fair value narrative paints Philip Morris International as 6.2% undervalued, but the current P/E of 25.5x tells a tougher story. It sits above the peer average of 23.3x and even above a fair ratio of 25.3x. This points to limited valuation slack if sentiment cools.

For investors who prefer to work from earnings multiples, the key question is whether paying more than both peers and the fair ratio feels like justified conviction, or tighter room for error if smoke free growth or regulation do not fully match expectations.

Next Steps

Sentiment around Philip Morris International in this article is mixed, so if you care about both risk and reward, consider acting promptly and weigh the full picture for yourself by reviewing the 3 key rewards and 1 important warning sign

Looking for more ideas beyond Philip Morris International?

If Philip Morris International has sharpened your focus on quality and price, it is worth widening the lens to other opportunities that could complement your portfolio.

• Spot potential bargains with strong fundamentals by checking out the 44 high quality undervalued stocks before prices move away from you.
• Strengthen your income stream by reviewing the 9 dividend fortresses that offer higher yields with a focus on resilience.
• Balance return potential with stability by scanning the 73 resilient stocks with low risk scores that score well on risk controls and consistency.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.